| MeSH term | MeSH ID | Detail |
|---|---|---|
| Atherosclerosis | D050197 | 85 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Glioma | D005910 | 112 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Xiang GD et al. | Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes. | 2009 | Diabet. Med. | pmid:19388970 |
| Ohishi M et al. | Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. | 2009 | Am. J. Pathol. | pmid:19389927 |
| Mogi M and Kondo A | Down-regulation of mTOR leads to up-regulation of osteoprotegerin in bone marrow cells. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19393224 |
| Schwartz Z et al. | Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces. | 2009 | Biomaterials | pmid:19395022 |
| Miheller P et al. | Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. | 2009 | Inflamm. Bowel Dis. | pmid:19408329 |
| Kook SH et al. | Mechanical force inhibits osteoclastogenic potential of human periodontal ligament fibroblasts through OPG production and ERK-mediated signaling. | 2009 | J. Cell. Biochem. | pmid:19206164 |
| Chen BL et al. | [Effect of total flavone of Epimedium on expression of bone OPG, OPGL mRNA in ovariectomized rats]. | 2009 | Zhongguo Gu Shang | pmid:19408755 |
| Wu XT et al. | Coumestrol promotes proliferation and osteoblastic differentiation in rat bone marrow stromal cells. | 2009 | J. Biomed. Mater. Res. Part B Appl. Biomater. | pmid:19165772 |
| O'Connor RD et al. | Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. | 2009 | Bone | pmid:19414073 |
| Li Q et al. | 17beta-Estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL/OPG balance in vitro. | 2009 | Leuk. Res. | pmid:19167063 |
| Han X et al. | Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. | 2009 | Oral Microbiol. Immunol. | pmid:19416447 |
| Corallini F et al. | The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. | 2009 | Rheumatology (Oxford) | pmid:19168833 |
| Doumouchtsis K et al. | Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease. | 2009 | Ther Apher Dial | pmid:19379170 |
| Sato MM et al. | Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. | 2009 | Genes Cells | pmid:19170762 |
| Jørgensen GM et al. | Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity. | 2009 | Eur. J. Endocrinol. | pmid:19380455 |
| Fili S et al. | Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors. | 2009 | Cancer Lett. | pmid:19201081 |
| Wada Y et al. | Enamel matrix derivative neutralized the effect of lipopolysaccharide on osteoprotegerin and receptor activator of nuclear factor kappa B ligand expression of osteoblasts. | 2009 | Arch. Oral Biol. | pmid:19201394 |
| Wang AY | Vascular and other tissue calcification in peritoneal dialysis patients. | 2009 | Perit Dial Int | pmid:19270239 |
| Honsawek S et al. | Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. | 2009 | Pediatr. Surg. Int. | pmid:19184056 |
| Kim YD et al. | Expression of receptor activator of nuclear factor -kappaB ligand, receptor activator of nuclear factor -kappaB, and osteoprotegerin, following low-level laser treatment on deproteinized bovine bone graft in rats. | 2009 | Lasers Med Sci | pmid:18825474 |
| Kook SH et al. | Mechanical force augments the anti-osteoclastogenic potential of human gingival fibroblasts in vitro. | 2009 | J. Periodont. Res. | pmid:18842115 |
| Zhou Y et al. | The role of estrogen in osteogenetic cytokine expression in human periodontal ligament cells. | 2009 | Int J Periodontics Restorative Dent | pmid:19888494 |
| Zhang Y et al. | Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet. | 2009 | Bone | pmid:18848653 |
| Rashid G et al. | Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C. | 2009 | Am. J. Physiol. Renal Physiol. | pmid:18945829 |
| Secchiero P et al. | Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye. | 2009 | J. Cell. Physiol. | pmid:18780288 |
| González-Calvin JL et al. | Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis. | 2009 | J. Clin. Endocrinol. Metab. | pmid:19897681 |
| Tortelli F et al. | Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. | 2009 | Tissue Eng Part A | pmid:19292676 |
| Zhu H et al. | Tumor necrosis factor-alpha alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function. | 2009 | Stem Cells Dev. | pmid:19374589 |
| Zhang N et al. | Relationship between age-related serum concentrations of TGF-beta1 and TGF-beta2 and those of osteoprotegerin and leptin in native Chinese women. | 2009 | Clin. Chim. Acta | pmid:19361465 |
| Huang HH et al. | Functional alpha1- and beta2-adrenergic receptors in human osteoblasts. | 2009 | J. Cell. Physiol. | pmid:19334040 |
| Klejna K et al. | OPG/RANK/RANKL signaling system and its significance in nephrology. | 2009 | Folia Histochem. Cytobiol. | pmid:19995704 |
| Crespi R et al. | Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo. | 2009 | J. Periodontol. | pmid:19335078 |
| Suh KS et al. | Kaempferol attenuates 2-deoxy-d-ribose-induced oxidative cell damage in MC3T3-E1 osteoblastic cells. | 2009 | Biol. Pharm. Bull. | pmid:19336918 |
| Stolina M et al. | RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies. | 2009 | Arthritis Res. Ther. | pmid:20003323 |
| Shimizu M et al. | Variations in circulating osteoprotegerin and soluble RANKL during diurnal and menstrual cycles in young women. | 2009 | Horm. Res. | pmid:19339793 |
| Sziklai I et al. | Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss. | 2009 | Eur Arch Otorhinolaryngol | pmid:19340443 |
| McCarthy HS et al. | Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells. | 2009 | J. Cell. Physiol. | pmid:18814141 |
| Stolina M et al. | The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis. | 2009 | J. Clin. Immunol. | pmid:18726678 |
| Leibbrandt A and Penninger JM | RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. | 2009 | Adv. Exp. Med. Biol. | pmid:19731623 |
| D'Amelio P et al. | The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. | 2009 | J. Endocrinol. Invest. | pmid:19724159 |
| Blackwell KA et al. | Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures. | 2009 | Prostaglandins Other Lipid Mediat. | pmid:19744575 |
| Grundt A et al. | Direct effects of osteoprotegerin on human bone cell metabolism. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19748486 |
| Kwan Tat S et al. | Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. | 2009 | Rheumatology (Oxford) | pmid:19762475 |
| Rendina D et al. | Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases. | 2009 | Calcif. Tissue Int. | pmid:19763378 |
| Kim HN et al. | Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. | 2009 | Eur. J. Pharmacol. | pmid:19766111 |
| Van Campenhout A and Golledge J | Osteoprotegerin, vascular calcification and atherosclerosis. | 2009 | Atherosclerosis | pmid:19007931 |
| Schwartz Z et al. | Osteoprotegerin (OPG) production by cells in the osteoblast lineage is regulated by pulsed electromagnetic fields in cultures grown on calcium phosphate substrates. | 2009 | Ann Biomed Eng | pmid:19139991 |
| Lamoureux F et al. | Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. | 2009 | Cancer Res. | pmid:19147566 |
| Agarwal S et al. | Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis. | 2009 | Rheumatol. Int. | pmid:19052752 |
| Terekeci HM et al. | Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy. | 2009 | Exp. Clin. Endocrinol. Diabetes | pmid:19053023 |
| Philippou A et al. | Systemic cytokine response following exercise-induced muscle damage in humans. | 2009 | Clin. Chem. Lab. Med. | pmid:19445648 |
| Kusumi A et al. | Passage-affected competitive regulation of osteoprotegerin synthesis and the receptor activator of nuclear factor-kappaB ligand mRNA expression in normal human osteoblasts stimulated by the application of cyclic tensile strain. | 2009 | J. Bone Miner. Metab. | pmid:19449178 |
| Tang X and Meng H | Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells. | 2009 | Arch. Oral Biol. | pmid:19464673 |
| Luckhaus C et al. | Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. | 2009 | J Neural Transm | pmid:19468818 |
| Sigrist MK et al. | Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. | 2009 | Nephrol. Dial. Transplant. | pmid:19491380 |
| Mikami S et al. | Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. | 2009 | J. Pathol. | pmid:19455604 |
| Dong SS et al. | Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. | 2009 | Calcif. Tissue Int. | pmid:19458885 |
| Reid PE et al. | Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact. | 2009 | Mol. Cancer | pmid:19604388 |
| Xu R | Effect of whey protein on the proliferation and differentiation of osteoblasts. | 2009 | J. Dairy Sci. | pmid:19528578 |
| Pedrosa WF et al. | Immunohistochemical, tomographic and histological study on onlay bone graft remodeling. Part II: calvarial bone. | 2009 | Clin Oral Implants Res | pmid:19531103 |
| Xu Y et al. | Regulation of the response of the adult rat condyle to intermaxillary asymmetric force by the RANKL-OPG system. | 2009 | Angle Orthod | pmid:19537860 |
| Brennan TC et al. | Osteoblasts play key roles in the mechanisms of action of strontium ranelate. | 2009 | Br. J. Pharmacol. | pmid:19563530 |
| Lu TY et al. | DNA methylation and histone modification regulate silencing of OPG during tumor progression. | 2009 | J. Cell. Biochem. | pmid:19565568 |
| Chuang FH et al. | Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma. | 2009 | J. Oral Pathol. Med. | pmid:19566744 |
| Musacchio E et al. | The tumor necrosis factor-{alpha}-blocking agent infliximab inhibits interleukin 1beta (IL-1beta) and IL-6 gene expression in human osteoblastic cells. | 2009 | J. Rheumatol. | pmid:19567627 |
| Tang TH et al. | Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid. | 2009 | J. Clin. Periodontol. | pmid:19570104 |
| Hofsø D et al. | Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. | 2009 | Eur. J. Endocrinol. | pmid:19542241 |
| George A and Evans CA | Detection of root resorption using dentin and bone markers. | 2009 | Orthod Craniofac Res | pmid:19627525 |
| Hartsfield JK | Pathways in external apical root resorption associated with orthodontia. | 2009 | Orthod Craniofac Res | pmid:19627526 |
| Hagedorn C et al. | Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter. | 2009 | Arterioscler. Thromb. Vasc. Biol. | pmid:19661483 |
| Robinson H et al. | Basic synovial biology and immunopathology in psoriatic arthritis. | 2009 | J Rheumatol Suppl | pmid:19661529 |
| Wang J et al. | [Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients]. | 2009 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:19662974 |
| Zhang T et al. | The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. | 2009 | Biomaterials | pmid:19665222 |
| Polyzos SA et al. | The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone. | 2009 | Horm. Metab. Res. | pmid:19670154 |
| Buduneli N et al. | Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment. | 2009 | J. Periodontol. | pmid:19656027 |
| Lee HJ et al. | Effects of nicotine on antioxidant defense enzymes and RANKL expression in human periodontal ligament cells. | 2009 | J. Periodontol. | pmid:19656028 |
| Korostishevsky M et al. | Anthropometric and bone-related biochemical factors are associated with different haplotypes of ANKH locus. | 2008 Sep-Oct | Ann. Hum. Biol. | pmid:18821330 |
| Spelling P et al. | Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker? | 2008 Nov-Dec | Scand. J. Rheumatol. | pmid:18802807 |
| Reddi D et al. | Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells. | 2008 Nov-Dec | Microbes Infect. | pmid:18789397 |
| Ainola M et al. | Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis. | 2008 Mar-Apr | Clin. Exp. Rheumatol. | pmid:18565244 |
| Kwan Tat S et al. | The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. | 2008 Mar-Apr | Clin. Exp. Rheumatol. | pmid:18565252 |
| Prezelj J et al. | Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women. | 2008 Mar-Apr | Menopause | pmid:17882010 |
| Kim JG et al. | Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women. | 2008 Mar-Apr | Menopause | pmid:17925661 |
| Ciacli C et al. | [Bone turnover markers evaluation in psoriatic arthritis]. | 2008 Jul-Sep | Rev Med Chir Soc Med Nat Iasi | pmid:20201244 |
| Sennels H et al. | Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. | 2008 Jul-Aug | Scand. J. Rheumatol. | pmid:18612923 |
| Nicolin V et al. | Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis. | 2008 Jan-Mar | Eur J Histochem | pmid:18502726 |
| Morse LR et al. | Age and motor score predict osteoprotegerin level in chronic spinal cord injury. | 2008 Jan-Mar | J Musculoskelet Neuronal Interact | pmid:18398265 |
| Uemura H et al. | Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women. | 2008 Jan-Feb | Menopause | pmid:17545921 |
| Delmas PD | Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases. | 2008 Apr-Jun | J Clin Densitom | pmid:18375161 |
| Pivonka P et al. | Model structure and control of bone remodeling: a theoretical study. | 2008 | Bone | pmid:18514606 |
| Poulsen RC et al. | Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. | 2008 | Prostaglandins Other Lipid Mediat. | pmid:18077200 |
| Cochran DL | Inflammation and bone loss in periodontal disease. | 2008 | J. Periodontol. | pmid:18673012 |
| Huang SH et al. | [Guling tablets promotes the proliferation and mineralization and regulates OPG/RANKL/M-CSF expression of osteoblasts via the p38 MAPK pathway in vitro]. | 2008 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:18676248 |
| Chakravarti A et al. | Normal human primary CD4+ T lymphocytes synthesize and release functional osteoprotegerin in vitro. | 2008 | Lab. Invest. | pmid:18040268 |
| Chen R et al. | Local osteoprotegerin gene transfer to periodontal tissue inhibits lipopolysaccharide-induced alveolar bone resorption. | 2008 | J. Periodont. Res. | pmid:18086145 |
| Mikami S et al. | Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. | 2008 | Hypertens. Res. | pmid:18716364 |
| Morishita M et al. | Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. | 2008 | J. Rheumatol. | pmid:18260178 |
| Geneviève D et al. | Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome). | 2008 | Nat. Genet. | pmid:18264100 |
| Takai S et al. | (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK. | 2008 | Mediators Inflamm. | pmid:19148296 |
| Heymann MF et al. | OPG, RANK and RANK ligand expression in thyroid lesions. | 2008 | Regul. Pept. | pmid:18367263 |